Physician profile
Simon Akl
NPI 1396121190
$470.11
in general payments reported to CMS, 2019-2025
17 companies · $59.61 in 2025
The $59.61 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.49 · 2020: $36.00 · 2021: $57.07 · 2022: $79.00 · 2023: $95.29 · 2024: $103 · 2025: $59.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $257.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $88.36 | 2020-2025 | |
| Mannkind Corporation | $48.72 | 2022-2024 | |
| Abbott Laboratories | $44.91 | 2021-2023 | Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $34.81 | 2019-2024 | Dificid, Pifeltro, Delstrigo |
| Abbvie INC. | $29.02 | 2024 | |
| Glaxosmithkline, LLC. | $26.66 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.63 | 2024 | Lifevest |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.07 | 2025 | Xifaxan |
| Hologic Sales and Service, LLC | $21.89 | 2021 | |
| Nevro Corp. | $19.31 | 2023 | Senza |
| Gilead Sciences, INC. | $19.00 | 2023 | |
| Organon LLC | $17.83 | 2021 | |
| Dexcom, INC. | $17.20 | 2025 | Dexcom G6 Transmitter |
| Endogastric Solutions, INC | $15.33 | 2023 | Esophyx |
| Boston Scientific Corporation | $15.29 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.11 | 2024 | |
| Sanofi Pasteur INC. | $11.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Akl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.